First Trust Advisors’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-32,046
Closed -$219K 2485
2022
Q2
$219K Buy
32,046
+151
+0.5% +$1.54K ﹤0.01% 2367
2022
Q1
$450K Sell
31,895
-1,851
-5% -$24.8K ﹤0.01% 2280
2021
Q4
$489K Buy
33,746
+22,070
+189% +$314K ﹤0.01% 2296
2021
Q3
$165K Buy
+11,676
New +$180K ﹤0.01% 2471

Other funds holding BVS

First Trust Advisors's BVS Position: Q3 2022 in Review

First Trust Advisors sold out of Bioventus (BVS) in Q3 2022, closing a stake of 32,046 shares — an estimated $219K sold.

First Trust Advisors first reported a position in BVS in Q3 2021 and held it in 4 quarters. The position peaked at $489K in Q4 2021. 94 funds tracked by Wall St. Rank hold BVS as of Q3 2022.

  • First Trust Advisors reported no remaining Bioventus position as of Q3 2022 after selling out during the quarter.
  • First Trust Advisors sold 32,046 Bioventus shares in Q3 2022, an estimated $219K.
  • First Trust Advisors first reported a position in Bioventus in Q3 2021 and held it in 4 quarters.
  • First Trust Advisors's Bioventus position peaked at $489K in Q4 2021.
  • 94 funds tracked by Wall St. Rank held Bioventus as of Q3 2022.

Based on First Trust Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.